Providing a new therapy or medical device to patients who will benefit generally requires commercial development. Development strategies are informed in part by patent laws governing ownership of intellectual property (IP), a complex landscape that must be navigated by non-profit organizations focused on advancing the development of new therapies for unmet medical needs. Join us for a discussion of the opportunities and challenges that non-profit organizations face in developing an IP strategy that will foster their mission effectively. Topics to be considered include:

• Defining appropriate IP ownership expectations when awarding research grants.
• Balancing research institution expectations of royalty returns with overall development investments and healthcare costs.
• Managing conflicts of interest to ensure that patient benefit and safety remain the top priority.